Chanakya Kodishala Online

in Ohio, where he continues to provide direct patient care while advancing his medical expertise. At the Forefront of Rheumatology Research

This philosophy manifests in his product design cycles. He insists on "shadow-mode" testing, where new algorithms run parallel to human underwriters for months. Only when the AI matches or exceeds human empathy (not just accuracy) is it deployed live. This cautious, hybrid approach has saved several fintechs from the PR disasters of algorithmically rejecting deserving borrowers due to a data glitch.

As Rohan progressed through the rigorous curriculum, he began to appreciate the profound impact of coding on the world. He learned to craft elegant solutions to complex problems, to optimize systems for efficiency and scalability, and to push the boundaries of what was thought possible. Chanakya Kodishala

: Because cardiovascular disease is a significant risk factor for cognitive issues in RA patients, keeping your blood pressure and cholesterol in check is a "two-for-one" win for your heart and your head. Keep Moving (Gently)

A pivotal phase of Dr. Kodishala's career was his appointment as a . At Mayo Clinic, he focused on "identifying the risk factors for cognitive dysfunction in patients with rheumatoid arthritis," contributing to a growing body of knowledge regarding the extra-articular manifestations of RA. in Ohio, where he continues to provide direct

Dr. Chanakya Kodishala is an emerging researcher and physician in the field of rheumatology, known for his dedicated work on the intersections of autoimmune conditions, cardiovascular health, and cognitive impairment. Currently associated with the prestigious in Rochester, Minnesota, Dr. Kodishala has contributed to significant academic literature focusing on patient-specific risk factors in chronic inflammatory diseases.

Through his abstract presentations at major annual summits—such as the American College of Rheumatology (ACR) Convergence—Dr. Kodishala contributes data that changes clinical guidelines. By demonstrating that rheumatoid arthritis is a multi-system, neuro-threatening illness rather than a localized joint disease, his research encourages clinicians to adopt a holistic approach to patient care. This includes aggressive screening for cardiovascular and cognitive anomalies early in the diagnosis of autoimmune diseases. Only when the AI matches or exceeds human

: He actively examined the definitive role of rheumatoid arthritis flares on accelerated cognitive decline.